Is Savaria’s Record Gross Margin and Savaria One Momentum Reshaping the Investment Case for TSX:SIS?
- Earlier this month, Savaria Corporation reported third quarter 2025 results, highlighting a 5.2% rise in revenue and a record gross margin of 39.2%, as operational enhancements from its Savaria One project gained traction.
- An especially interesting insight is that the Savaria One project, now completed, is expected to increase earnings per share by the end of 2026, potentially supporting future investment or acquisition activity.
- We’ll examine how the record-setting gross margin and operational improvements may alter Savaria’s broader investment narrative and outlook.
AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Savaria Investment Narrative Recap
To be a Savaria shareholder, one must believe that aging demographics and increased demand for home accessibility can support steady revenue gains, even as short-term risks such as macroeconomic volatility in Europe and potential margin plateauing remain front of mind. While the recent Q3 results showed a 5.2% revenue increase and another record gross margin, these operational milestones are unlikely to fundamentally shift the most significant near-term catalyst: the successful launch and market adoption of new products. The biggest risk, the possibility that persistent subsidy cuts or fiscal tightening in key European markets will weigh on revenues and undermine international diversification, does not appear materially diminished by the latest update.
Among recent announcements, Savaria’s confirmed 5-8% top-line growth guidance for 2025 is most relevant to the operational improvements just reported. This target now appears more achievable given margin expansion and efficiency gains from the completed Savaria One project, but actual performance will still hinge on execution with new products and evolving economic conditions.
By contrast, investors should be aware of how ongoing government subsidy reductions in Europe might still affect growth…
Read the full narrative on Savaria (it's free!)
Savaria's narrative projects CA$1.1 billion revenue and CA$128.4 million earnings by 2028. This requires 6.0% yearly revenue growth and a CA$74.1 million earnings increase from the current earnings of CA$54.3 million.
Uncover how Savaria's forecasts yield a CA$25.79 fair value, a 15% upside to its current price.
Exploring Other Perspectives
Ten individual fair value estimates from the Simply Wall St Community span from CA$16 to CA$35.12, showing strong disagreement on Savaria's potential. With risks around European revenue exposure and a focus on execution, investors should consider how divergent views could shape expectations for future results.
Explore 10 other fair value estimates on Savaria - why the stock might be worth as much as 56% more than the current price!
Build Your Own Savaria Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Savaria research is our analysis highlighting 4 key rewards that could impact your investment decision.
- Our free Savaria research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Savaria's overall financial health at a glance.
Contemplating Other Strategies?
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
- We've found 16 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
- This technology could replace computers: discover 28 stocks that are working to make quantum computing a reality.
- These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Savaria might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com